Florabile Plus
Natural health product licensed in Canada
- Licence holder
- Wampole Group L.P.
- NPN or DIN-HM
- 80029869
- Status
- Active licence
- Licence date
- 27 February 2012
- Revision date
- 15 September 2026
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cynara scolymus Source : Feuille Extraction ratio : 4:1 Dry plant equivalent : 300 mg | 75 mg | Not calculated |
| Silybum marianum Source : Grain(s) Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Peumus boldus Source : Feuille Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
| Fumaria officinalis Source : Parties aériennes | 50 mg | Not calculated |
Non-medicinal ingredients
Crosscarmellose sodium, Carmine, Eau purifiée, Povidone, Stéarate de magnésium, Calcium Carbonate 90 DC, Microcrystalline cellulose, Talc, Cire d'abeille, Ethanol, Shellac, Gomme arabique, Cire de carnauba, Titanium dioxide (CI 77891), Alcool éthylique, sucre, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 days |
Uses authorised in Canada
Aide à maintenir les foncions hépatiques du foie. Le boldo est utilisé traditionnellement en phytothérapie pour soigner la digestion difficile (dyspepsie) et pour stimuler la digestion.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Ce produit peut être difficile à digérer par certaines personnes souffiant de dyspepsie. Peut causer de légères diarrhées et de l'irritation stomachale. Une hypersensibilité, telle une allergie, peut se manifester. Si tel est cas, cesser l'utilisation.
Source
Official Health Canada record, licence 80029869
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.